subunit herpes zoster vaccine

Vaccineexperimental

Clinical trial activity

14 trials · 10 clinical orgs · 0 marketing orgs

Phase 1
3
Phase 2
9
Phase 3
5
Phase 4
3

Earliest trial started Sep 30, 2010 (NCT01165203)

Timeline

2010s

  1. Jan 1, 2010

    Earliest Phase 2 Sponsor(trial)

  2. Jan 1, 2018

    Earliest Phase 3 Sponsor(trial)

2020s

  1. Jan 1, 2020

    Earliest Phase 1 Sponsor(trial)

Indications

Approved for

Mechanism of action

Chemistry & pharmacology

Oral

No

Parenteral

No

Topical

No

Clinical trials

NCT IDPhaseStart dateSponsor(s)
NCT06932523Phase 1/Phase 2 (Phase 2)Jun 1, 2025China National Biotec Group Co., Ltd
NCT06088745Phase 3Sep 28, 2023Government of China
NCT05856084Phase 2May 7, 2023Government of China, MAXVAX Biotechnology Limited Liability Company
NCT05636436Phase 1Dec 9, 2022Government of China, MAXVAX Biotechnology Limited Liability Company
NCT05559671Phase 4Nov 15, 2022New York University
NCT04748939Phase 4Nov 30, 2021Tuen Mun Hospital, Hong Kong
NCT05082688Phase 2Sep 20, 2021GlaxoSmithKline, Radboud University
NCT04869982Phase 4May 14, 2021GlaxoSmithKline
NCT04210752Phase 1Feb 1, 2020EyeGene Inc., Novotech
NCT04176939Phase 3Dec 9, 2019GlaxoSmithKline
NCT04091451Phase 3Sep 17, 2019GlaxoSmithKline
NCT03685682Phase 3May 25, 2018University of Toronto
NCT03439657Phase 3Apr 12, 2018GlaxoSmithKline
NCT01165203Phase 2Sep 30, 2010GlaxoSmithKline
Showing 14 of 14 trials
Page 1 / 1

Organizations

Research & Development (10)

OrganizationOrg typeTrialsAs lead sponsorPhasesEarliest year
GlaxoSmithKlineFor profit6532010
Government of ChinaGovernment3132022
MAXVAX Biotechnology Limited Liability CompanyFor profit2222022
China National Biotec Group Co., LtdFor profit1112025
EyeGene Inc.For profit1112020
New York UniversityAcademic/Hospital1112022
NovotechFor profit1012020
Radboud UniversityAcademic/Hospital1112021
Tuen Mun Hospital, Hong KongAcademic/Hospital1112021
University of TorontoAcademic/Hospital1112018
10 organizations
Page 1 / 1